IF1 And ApoA-I Serum Concentrations, but Not HDL-cholesterol, Predict Mortality in Coronary Artery Disease Patients: The Genes Study

被引：0
|
作者：
Genoux, Annelise
Ruidavets, Jean-Bernard
Ferrieres, Jean
Bongard, Vanina
Vervueren, Paul-Louis
Combes, Guillaume
Taraszkiewicz, Dorota
Elbaz, Meyer
Perret, Bertrand
Martinez, Laurent O.
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
HDL; Apolipoproteins; Cardiovascular disease prevention; Biomarkers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18834
引用
收藏
页数：4
相关论文
共 50 条
  • [21] ASSOCIATION BETWEEN SERUM HDL-CHOLESTEROL CONCENTRATION AND SEVERITY OF CORONARY-ARTERY DISEASE (CAD) DETERMINED BY CINEANGIOGRAPHY
    NAITO, HK
    CLINICAL CHEMISTRY, 1980, 26 (07) : 966 - 966
  • [22] Different SCARB1 Locus Variants Associate With Hdl-Cholesterol and the Risk of Coronary Artery Disease
    Helgadottir, Anna
    Sulem, Patrick
    Thorgeirsson, Gudmundur
    Olafsson, Isleifur
    Eyjolfsson, Gudmundur I.
    Sigurdardottir, Olof
    Thorsteinsdottir, Unnur
    Gudbjartsson, Daniel F.
    Holm, Hilma
    Stefansson, Kari
    CIRCULATION, 2016, 134
  • [23] Extremely Low Hdl-Cholesterol and Premature Vascular Disease in Patients With Combined ABCA1 and APOA1 Mutations
    Koopal, Charlotte
    Visseren, Frank L.
    Westerink, Jan
    CIRCULATION, 2013, 128 (22)
  • [24] Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study
    Kurogi, Kazumasa
    Sugiyama, Seigo
    Sakamoto, Kenji
    Tayama, Shinji
    Nakamura, Shinichi
    Biwa, Takeshi
    Matsui, Kunihiko
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2013, 62 (1-2) : 87 - 94
  • [25] An index of fasting glucose and HDL-cholesterol is a strong predictor for death and cardiovascular events in patients with coronary artery disease
    Ohrvik, J.
    Malmberg, K.
    Ryden, L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 851 - 851
  • [26] Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol in statin-treated patients with coronary artery disease
    Javorsky, M.
    Gasperikova, D.
    Ukropec, J.
    Sedlakova, B.
    Riecansky, I.
    Krizanova, O.
    Sebokova, E.
    Dobrikova, M.
    Klimes, I.
    Tkac, I.
    DIABETOLOGIA, 2007, 50 : S511 - S511
  • [27] Serum HDL-cholesterol and N-3 Polyunsaturated Fatty acid levels are determinant factors of arterial remodeling in patients with coronary artery disease
    Toyama, K.
    Isshiki, A.
    Ando, T.
    Inoue, Y.
    Kirimura, M.
    Kamiyama, T.
    Sasaki, O.
    Ito, H.
    Nishioka, T.
    Yoshimoto, N.
    EUROPEAN HEART JOURNAL, 2013, 34 : 304 - 304
  • [28] Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease
    Masuda, Daisaku
    Yamashita, Shizuya
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (01) : 8 - 10
  • [29] SERUM HDL-CHOLESTEROL, APO-A-I AND APO-E LEVELS IN PATIENTS WITH ABNORMAL CORONARY-ARTERIES
    TAN, MH
    WELDON, KL
    ALBERS, JJ
    CHEUNG, MC
    HAVEL, RJ
    VIGNE, JL
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1980, 3 (3-4): : 225 - 232
  • [30] Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients
    Koch, M
    Kutkuhn, B
    Trenkwalder, E
    Bach, D
    Grabensee, B
    Dieplinger, H
    Kronenberg, F
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (12): : 1889 - 1898
12345